In terms of volume, the volume of drugs prescribed to patients reached 166 million packs. The retail channel registered an 8.6% drop and distribution via hospitals stalled (plus 0.3%).
Sales in public pharmacies decreased by 3% for prescription drugs and by 17.4% for OTC ones.
By value, Rx drugs registered a 9.2% plus in the retail channel, while OTC ones declined by 12.6%.
During the April 2025-March 2026 period, the total value of the pharma market stood at RON37.74 billion, up 8%.
The ranking of pharmaceutical companies is led by AstraZeneca, which boasted the highest sales by value in the first quarter, with RON554 million, followed by SunPharma with RON451.9 million and Zentiva with RON381.4 million.
(English version by Catalina Apostoiu)